FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FIGF | C-fos induced growth factor (vascular endothelial growth factor D) | Cancer-related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GAB1 | GRB2-associated binding protein 1 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GAB2 | GRB2-associated binding protein 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNB1 | Guanine nucleotide binding protein (G protein), beta polypeptide 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNB2 | Guanine nucleotide binding protein (G protein), beta polypeptide 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNB3 | Guanine nucleotide binding protein (G protein), beta polypeptide 3 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNB4 | Guanine nucleotide binding protein (G protein), beta polypeptide 4 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNB5 | Guanine nucleotide binding protein (G protein), beta 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNG11 | Guanine nucleotide binding protein (G protein), gamma 11 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNG12 | Guanine nucleotide binding protein (G protein), gamma 12 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
GNG2 | Guanine nucleotide binding protein (G protein), gamma 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNG5 | Guanine nucleotide binding protein (G protein), gamma 5 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNG7 | Guanine nucleotide binding protein (G protein), gamma 7 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GRB2 | Growth factor receptor-bound protein 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GRIN1 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Tissue enriched |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
GRIN2B | Glutamate receptor, ionotropic, N-methyl D-aspartate 2B | Disease related genes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
HGF | Hepatocyte growth factor (hepapoietin A; scatter factor) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
HRAS | Harvey rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins RAS pathway related proteins
| | | | | Group enriched |
IGF1 | Insulin-like growth factor 1 (somatomedin C) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKG | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
JMJD7-PLA2G4B | JMJD7-PLA2G4B readthrough | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KITLG | KIT ligand | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KRAS | Kirsten rat sarcoma viral oncogene homolog | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR2 | Kinase suppressor of ras 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK10 | Mitogen-activated protein kinase 10 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK8 | Mitogen-activated protein kinase 8 | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK9 | Mitogen-activated protein kinase 9 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
MLLT4 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MRAS | Muscle RAS oncogene homolog | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |